Literature DB >> 35512714

The role of 11C-methionine PET in patients with newly diagnosed WHO grade 2 or 3 gliomas.

Norbert Galldiks1,2,3, Philipp Lohmann4, Karl-Josef Langen2,3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35512714      PMCID： PMC9435479          DOI： 10.1093/neuonc/noac120

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  8 in total

Review 1.  Recent advances of PET in the diagnosis of brain tumors.

Authors:  K J Langen; M Weckesser
Journal:  Front Radiat Ther Oncol       Date:  1999

Review 2.  Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Authors:  Nathalie L Albert; Michael Weller; Bogdana Suchorska; Norbert Galldiks; Riccardo Soffietti; Michelle M Kim; Christian la Fougère; Whitney Pope; Ian Law; Javier Arbizu; Marc C Chamberlain; Michael Vogelbaum; Ben M Ellingson; Joerg C Tonn
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

3.  Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients.

Authors:  Norbert Galldiks; Marcus Unterrainer; Natalie Judov; Gabriele Stoffels; Marion Rapp; Philipp Lohmann; Franziska Vettermann; Veronika Dunkl; Bogdana Suchorska; Jörg C Tonn; Friedrich-Wilhem Kreth; Gereon R Fink; Peter Bartenstein; Karl-Josef Langen; Nathalie L Albert
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

4.  Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience.

Authors:  Timothée Zaragori; Angelo Castello; Eric Guedj; Antoine Girard; Norbert Galldiks; Nathalie L Albert; Egesta Lopci; Antoine Verger
Journal:  Clin Nucl Med       Date:  2021-01       Impact factor: 7.794

5.  Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group.

Authors:  Norbert Galldiks; Maximilian Niyazi; Anca L Grosu; Martin Kocher; Karl-Josef Langen; Ian Law; Giuseppe Minniti; Michelle M Kim; Christina Tsien; Frederic Dhermain; Riccardo Soffietti; Minesh P Mehta; Michael Weller; Jörg-Christian Tonn
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

6.  Diagnosis of Brain Tumors Using Amino Acid Transport PET Imaging with 18F-fluciclovine: A Comparative Study with L-methyl-11C-methionine PET Imaging.

Authors:  Naohiro Tsuyuguchi; Yuzo Terakawa; Takehiro Uda; Kosuke Nakajo; Yonehiro Kanemura
Journal:  Asia Ocean J Nucl Med Biol       Date:  2017

7.  Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas.

Authors:  Gaia Ninatti; Martina Sollini; Beatrice Bono; Noemi Gozzi; Daniil Fedorov; Lidija Antunovic; Fabrizia Gelardi; Pierina Navarria; Letterio S Politi; Federico Pessina; Arturo Chiti
Journal:  Neuro Oncol       Date:  2022-09-01       Impact factor: 13.029

Review 8.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Pieter Wesseling; Daniel J Brat; Ian A Cree; Dominique Figarella-Branger; Cynthia Hawkins; H K Ng; Stefan M Pfister; Guido Reifenberger; Riccardo Soffietti; Andreas von Deimling; David W Ellison
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 13.029
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.